Volume 96, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



We determined the prevalence of IgG antibodies to hepatitis E virus (anti-HEV IgG) among travelers attending Boston-area travel health clinics from 2009 to 2010. Pre-travel samples were available for 1,356 travelers, with paired pre- and post-travel samples for 450 (33%). Eighty of 1,356 (6%) pre-travel samples were positive for anti-HEV IgG. Compared with participants who had never lived in nor traveled to a highly endemic country, the pre-travel prevalence odds ratio (POR) of anti-HEV IgG among participants born in or with a history of previous travel to a highly endemic country was increased (POR = 4.8, 95% CI = 2.3–10.3 and POR = 2.6, 95% CI = 1.4–5.0, respectively). Among participants with previous travel to a highly endemic country, anti-HEV IgG was associated with age > 40 years (POR = 3.7, 95% CI = 1.3–10.2) and travel history to ≥ 3 highly endemic countries (POR = 2.7, 95% CI = 1.2–5.9). Two participants may have contracted HEV infection during their 2009–2010 trip.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Navaneethan U, Mohajer MA, Shata MT, , 2008. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 28: 11901199.[Crossref] [Google Scholar]
  2. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L, , 2008. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358: 811817.[Crossref] [Google Scholar]
  3. World Health Organization, 2015. Hepatitis E. Available at: http://www.who.int/mediacentre/factsheets/fs280/en/. Accessed August 31, 2016. [Google Scholar]
  4. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST, , 2012. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 55: 988997.[Crossref] [Google Scholar]
  5. Lu L, Li C, Hagedorn CH, , 2006. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 16: 536.[Crossref] [Google Scholar]
  6. Khuroo MS, Khuroo MS, , 2016. Hepatitis E: an emerging global disease—from discovery towards control and cure. J Viral Hepat 23: 6879.[Crossref] [Google Scholar]
  7. Kmush BL, Nelson KE, Labrique AB, , 2015. Risk factors for hepatitis E virus infection and disease. Expert Rev Anti-infe 13: 4153.[Crossref] [Google Scholar]
  8. Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Teo CG, Holmberg SD, , 2015. Decline in hepatitis E virus antibody prevalence in the United States from 1988–1994 to 2009–2010. J Infect Dis 211: 366373.[Crossref] [Google Scholar]
  9. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE, , 2009. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis 200: 4856.[Crossref] [Google Scholar]
  10. Tarrago D, Lopez-Velez R, Turrientes C, Baquero F, Mateos ML, , 2000. Prevalence of hepatitis E antibodies in immigrants from developing countries. Eur J Clin Microbiol Infect Dis 19: 309311.[Crossref] [Google Scholar]
  11. Scotto G, Martinelli D, Giammario A, Prato R, Fazio V, , 2013. Prevalence of antibodies to hepatitis E virus in immigrants: a seroepidemiological survey in the district of Foggia (Apulia-southern Italy). J Med Virol 85: 261265.[Crossref] [Google Scholar]
  12. Mast EE, Kuramoto IK, Favorov MO, Schoening VR, Burkholder BT, Shapiro CN, Holland PV, , 1997. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in northern California. J Infect Dis 176: 3440.[Crossref] [Google Scholar]
  13. Elfrink F, van Rijekevorsal GGC, van Gool T, van den Hoek A, Sonder GJB, , 2012. Low risk of hepatitis E among Dutch short-term travelers. J Travel Med 19: 202204.[Crossref] [Google Scholar]
  14. Potasman I, Koren L, Peterman M, Srugo I, , 2000. Lack of hepatitis E infection among backpackers to tropical countries. J Travel Med 7: 208210.[Crossref] [Google Scholar]
  15. Ooi WW, Gawoski JM, Yarbough PO, Pankey GA, , 1999. Hepatitis E seroconversion in United States travelers abroad. Am J Trop Med Hyg 61: 822824. [Google Scholar]
  16. Sanchez-Vegas C, Hamer DH, Chen LH, Wilson ME, Benoit C, Hunsperger E, MacLeod WB, Jentes ES, Ooi WW, Karchmer AW, Kogelman L, Yanni E, Marano N, Barnett ED, , 2013. Prevalence of dengue virus infection in United States travelers who have lived in or traveled to dengue-endemic countries. J Travel Med 20: 352360.[Crossref] [Google Scholar]
  17. Olivero RM, Hamer DH, MacLeod WB, Benoit CM, Sanchez-Vegas C, Jentes ES, Chen LH, Wilson ME, Marano N, Yanni EA, Ooi WW, Karchmer AW, Kogelman L, Barnett ED, , 2016. Dengue virus seroconversion in travelers to dengue-endemic areas. Am J Trop Med Hyg 95: 11301136.[Crossref] [Google Scholar]
  18. Teo CG, Brunette GW, Kozarsky PM, Magill AJ, Shlim DR, Whatley A, , 2012. Hepatitis E. , eds. CDC Health Information for International Travel. New York, NY: Oxford University Press. [Google Scholar]
  19. Centers for Disease Control and Prevention, 1993. Hepatitis E among U.S. travelers, 1989–1992. Morb Mortal Wkly Rep 42: 14. [Google Scholar]
  20. Skidmore SJ, Yarbough PO, Gabor KA, Tam AW, Reyes GR, Flower AJE, , 1991. Imported hepatitis E in UK. Lancet 8756: 1541.[Crossref] [Google Scholar]
  21. Drobeniuc J, Greene-Montfort T, Lee NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, Novak RT, Sharapov UM, Tohme RA, Teshale E, Kamili S, Teo CG, , 2013. Laboratory-based surveillance for hepatitis E infection, United States, 2005–2012. Emerg Infect Dis 19: 218222.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 07 Sep 2016
  • Accepted : 16 Dec 2016
  • Published online : 30 Jan 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error